Unique ID issued by UMIN | UMIN000045364 |
---|---|
Receipt number | R000051778 |
Scientific Title | Examination of the Effect of Istradefylline on Postural Abnormalities in Parkinson's Disease Based on Photo Data (Retrospective study) |
Date of disclosure of the study information | 2021/10/01 |
Last modified on | 2024/03/13 16:29:53 |
Examination of the Effect of Istradefylline on Postural Abnormalities in Parkinson's Disease Based on Photo Data (Retrospective study)
Postural Abnormalities in Parkinson's Disease
Examination of the Effect of Istradefylline on Postural Abnormalities in Parkinson's Disease Based on Photo Data (Retrospective study)
Postural Abnormalities in Parkinson's Disease
Japan |
Parkinson's Disease
Neurology |
Others
NO
Examine the clinical effect of istradefylline on postural abnormalities in Parkinson's disease from photo data
Efficacy
Association between severity of postural abnormalities based on angle data prior to isradefylline treatment and changes in UDRS score before and after istradefylline treatment.
Observational
30 | years-old | <= |
Not applicable |
Male and Female
Patients who have already obtained written consent for the previous study (jRCTs051180185)
Patient whose angle data from photo has already been acquired
NA
31
1st name | Makio |
Middle name | |
Last name | Takahashi |
Kansai Medical University
Department of Neurodegenerative Disorders
573-1191
2-5-1 Shin-machi, Hirakata City, Osaka
072-804-0101
ta@kuhp.kyoto-u.ac.jp
1st name | Makio |
Middle name | |
Last name | Takahashi |
Kansai Medical University
Department of Neurodegenerative Disorders
573-1191
2-5-1 Shin-machi, Hirakata City, Osaka
072-804-0101
ta@kuhp.kyoto-u.ac.jp
Kitano Hospital, The Tazuke-Kofukai Medical Research Institute
Kyowa Kirin Co., Ltd.
Profit organization
Wakayama Medical University
Medical Ethics Committee of Kitano Hospital
2-4-20 Ohgimachi, Kita-Ku, Osaka
06-6131-2792
rinshou@kitano-hp.or.jp
NO
2021 | Year | 10 | Month | 01 | Day |
Not open to the public
Published
https://www.sciencedirect.com/science/article/pii/ S2405650223000515?via%3Dihub
31
Patients with more advanced postural abnormalites showed more consistent improvements in the UDRS total score with istradefylline.
2024 | Year | 03 | Month | 13 | Day |
2023 | Year | 12 | Month | 30 | Day |
Age, years 73.3 (7.7)
Female, n (%) 18 (58.1)
Body weight, kg 49.4 (9.6)
Duration of PD, years 6.2 (4.2)
Duration of motor complications, years 3.2 (4.4)
MMSE score 27.4 (2.1)
UDRS score 15.2 (3.7)
mH&Y score (on state) 2.4 (0.6)
mH&Y score (off state) 4.1 (1.1)
31 patients were enrolled and 24 completed the study. Overall, 7 patients discontinued the study: 3 due to AEs, 2 due to withdrawal of consent, and 2 based on the physician's decision.
Refer to the previous study (Takahashi et al., J Neurol Sci, 2022)
The change and percent change in the UDRS total score from week 0 to week 24 of istradefylline treatment.
No shared plan
No shared plan
Completed
2021 | Year | 06 | Month | 10 | Day |
2021 | Year | 07 | Month | 14 | Day |
2021 | Year | 10 | Month | 01 | Day |
2022 | Year | 06 | Month | 30 | Day |
2022 | Year | 06 | Month | 30 | Day |
2022 | Year | 06 | Month | 30 | Day |
2022 | Year | 12 | Month | 30 | Day |
This study is a retrospective study of clinical study (intervention study) (jRCTs051180185) for postural abnormalities in Parkinson's disease patients.
2021 | Year | 09 | Month | 03 | Day |
2024 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051778